Cough for 6 Weeks After Travel
The most likely diagnosis is postinfectious cough following a respiratory infection acquired during travel, and you should start with inhaled ipratropium bromide as first-line therapy after ruling out tuberculosis and pertussis. 1
Immediate Risk Stratification
At 6 weeks duration, this is a subacute cough (defined as 3-8 weeks), which sits at the critical transition point before becoming chronic. 1
Red Flags Requiring Urgent Evaluation
Check immediately for these concerning features that demand chest radiography and broader workup: 2, 3
- Hemoptysis (any amount)
- Vital sign abnormalities: heart rate ≥100 bpm, respiratory rate ≥24 breaths/min, temperature ≥38°C
- Systemic symptoms: fever, night sweats, unintentional weight loss
- Asymmetrical lung sounds or focal consolidation on examination
- Voice changes or hoarseness
If any red flags are present, obtain chest X-ray immediately before proceeding with empiric treatment. 2, 3
Critical Travel-Related Consideration: Tuberculosis
Given the travel history, tuberculosis must be actively excluded before assuming benign postinfectious cough. 1
When to Suspect TB
Screen for TB if the patient traveled to high-prevalence areas (sub-Saharan Africa, Southeast Asia, Eastern Europe, Latin America) or has: 1
- Cough ≥2 weeks in high-prevalence settings
- Systemic symptoms (fever, night sweats, weight loss)
- Known TB exposure during travel
- Immunocompromised status
TB Diagnostic Workup
If TB risk factors are present: 1
- Obtain chest radiograph looking for upper lobe infiltrates, cavitation, or lymphadenopathy
- Collect three sputum specimens for acid-fast bacilli smear and culture
- Consider tuberculin skin test or interferon-gamma release assay
In high TB prevalence areas, cough ≥2 weeks warrants screening even without other symptoms, as 10-13% of such patients have smear-positive pulmonary TB. 1
Second Critical Diagnosis: Pertussis
Before treating as simple postinfectious cough, actively evaluate for pertussis, especially given potential exposure during travel. 1, 3
Pertussis Clinical Features
Suspect pertussis if the patient reports: 1, 3
- Paroxysmal coughing episodes (sudden, uncontrollable coughing fits)
- Post-tussive vomiting (vomiting triggered by cough)
- Inspiratory whooping sound after coughing paroxysms
- Known exposure to confirmed pertussis case
Pertussis Diagnostic Testing
If pertussis is suspected: 1, 3
- Obtain nasopharyngeal aspirate or Dacron swab for culture (gold standard)
- Order paired acute and convalescent sera for fourfold increase in IgG or IgA antibodies to pertussis toxin
- Start macrolide antibiotic immediately without waiting for confirmation if clinical suspicion is high
Early treatment within the first few weeks diminishes coughing paroxysms and prevents transmission. 1, 3
Medication Review
Stop any ACE inhibitor immediately if the patient is taking one. 2, 4
ACE inhibitors cause persistent cough, and the median time to resolution after discontinuation is 26 days—which could explain ongoing symptoms even if the medication preceded travel. 2, 4
Most Likely Diagnosis: Postinfectious Cough
If TB and pertussis are excluded and no red flags are present, postinfectious cough is the most common cause of subacute cough, accounting for approximately 48% of cases. 1, 2
Pathophysiology
Multiple mechanisms contribute: 1
- Postviral airway inflammation
- Bronchial hyperresponsiveness
- Mucus hypersecretion and impaired mucociliary clearance
- Upper airway cough syndrome (postnasal drip)
- Transient asthma-like features
First-Line Treatment Algorithm
Step 1: Inhaled Ipratropium Bromide
Prescribe inhaled ipratropium bromide as the only evidence-based first-line therapy for postinfectious cough. 1, 2
- Approximately 70% response rate with Grade B evidence
- Typical dosing: 2-4 puffs (18-36 mcg) four times daily
- Trial for 2 weeks before escalating therapy
Do NOT prescribe antibiotics—they have no role in postinfectious cough as the cause is not bacterial infection. 1, 2
Step 2: If Ipratropium Fails After 2 Weeks
Add inhaled corticosteroids if cough adversely affects quality of life and persists despite ipratropium. 1
- Use moderate-to-high dose inhaled corticosteroid
- Continue for 2-4 weeks
Step 3: For Severe Paroxysms
Consider prednisone 30-40 mg daily for a short, finite period (5-7 days) only if: 1
- Cough is severely affecting quality of life
- Other common causes (upper airway cough syndrome, asthma, GERD) have been ruled out
- Ipratropium and inhaled corticosteroids have failed
Step 4: Central Antitussives as Last Resort
Consider codeine or dextromethorphan only when other measures fail. 1
Alternative Diagnoses if Treatment Fails
If the patient does not respond to ipratropium within 2 weeks, consider these alternative diagnoses that can masquerade as postinfectious cough: 2, 4
Upper Airway Cough Syndrome (UACS)
- Trial first-generation antihistamine-decongestant combination for 1-2 weeks
- Look for postnasal drip, throat clearing, nasal congestion
Asthma or Cough-Variant Asthma
- Perform spirometry with bronchodilator response
- Consider methacholine challenge testing if spirometry is normal
- Trial inhaled bronchodilators and corticosteroids
Gastroesophageal Reflux Disease (GERD)
- Initiate high-dose PPI therapy for at least 8 weeks
- Note: Acid suppression alone is no longer recommended as sole therapy; comprehensive GERD management is required 4
Nonasthmatic Eosinophilic Bronchitis (NAEB)
- Consider sputum eosinophil count or induced sputum analysis
- Trial inhaled corticosteroids if eosinophilia is present
Critical Timeline: The 8-Week Threshold
If cough persists beyond 8 weeks despite appropriate treatment, it transitions to chronic cough and requires full chronic cough workup. 1, 2
At that point, consider: 2
- High-resolution CT chest
- 24-hour esophageal pH monitoring
- Bronchoscopy
- Referral to specialized cough clinic
Common Pitfalls to Avoid
Do NOT prescribe antibiotics for postinfectious cough unless pertussis is confirmed or bacterial sinusitis is documented. 1, 2
Do NOT assume "just bronchitis" without excluding TB in a traveler, especially from high-prevalence areas. 1
Do NOT wait beyond 8 weeks to escalate evaluation if cough persists despite treatment. 1, 2
Do NOT ignore medication review—ACE inhibitors must be stopped before pursuing extensive workup. 2, 4
Do NOT use codeine or dextromethorphan as first-line therapy—they should only be considered when other measures fail. 1
Follow-Up Strategy
Schedule follow-up in 4-6 weeks to reassess if cough persists. 2
Use a validated cough severity or quality of life tool to objectively assess treatment response rather than relying solely on subjective reporting. 2